z-logo
open-access-imgOpen Access
HIV and Hepatitis C Virus Infection in the United States: Whom and How to Test
Author(s) -
Nivedha Panneer,
Erik Lontok,
Bernard M. Branson,
C. G. Teo,
Dan Chen,
Monica M. Parker,
Joanne D. Stekler,
Alfred DeMaria,
Veronica Miller
Publication year - 2014
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciu396
Subject(s) - medicine , hepatitis c virus , virology , human immunodeficiency virus (hiv) , test (biology) , hepatitis a virus , hepatitis c , virus , immunology , biology , paleontology
In the United States, of the 1.1 million persons infected with human immunodeficiency virus (HIV) and the 2.7 million infected with hepatitis C virus (HCV), approximately 16% and 50%, respectively, are unaware of their infection. Highly effective treatments have turned both diseases into manageable conditions, and in the case of hepatitis C, a disease that can be cured. Early diagnosis is imperative so that infected persons can take measures to stay healthy, get into care, benefit from therapy, and reduce the risk of transmission. In this report, we review current recommendations provided by the Centers for Disease Control and Prevention (CDC) and the United States Preventive Services Task Force on whom to screen for HIV and HCV infections, and recommendations from the CDC, the Association of Public Health Laboratories, and the Clinical and Laboratory Standards Institute on how to test for these infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom